Citius Oncology, Inc. (CTOR)
1.07
-0.02
(-1.83%)
USD |
NASDAQ |
Mar 05, 16:00
1.055
-0.02
(-1.40%)
After-Hours: 20:00
Citius Oncology Cash from Investing (TTM) : -10.19M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Citius Pharmaceuticals, Inc. | -10.15M |
| Amgen, Inc. | -1.943B |
| Amicus Therapeutics, Inc. | -46.43M |
| Soligenix, Inc. | -0.0039M |
| Tonix Pharmaceuticals Holding Corp. | -3.687M |